caa a22 4500 388041110 CHVBK 20180307125021.0 cr unu---uuuuu 161130e199806 xx s 000 0 eng 10.1017/S0813483900003211 doi S0813483900003211 pii (NATIONALLICENCE)cambridge-10.1017/S0813483900003211 Tonge Bruce J. Monash University Pharmacotherapy of School Refusal [Elektronische Daten] [Bruce J. Tonge] This paper reviews the role and indications for pharmacotherapy of children with school refusal. The psychopharmacological treatment of school refusal is based mainly on evidence of the effectiveness of certain drugs in the treatment of adult disorders. There is some evidence that tricyclic antidepressants and benzobiazepines may be specifically useful in the treatment of school refusal, but further research is warranted. Potentially serious side effects mean that drugs are best confined to cases where psychological treatments have not been effective or where drugs are used briefly as an adjunct to a broader psychological treatment plan. Drugs may also have a role in the specific treatment of comorbid conditions associated with school refusal. Any use of drugs should involve regular reviews to monitor response, compliance, and side effects. Copyright © The Author(s) 1998 Behaviour Change Cambridge University Press 15/2(1998-06), 98-106 0813-4839 15:2<98 1998 15 BEC https://doi.org/10.1017/S0813483900003211 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1017/S0813483900003211 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Tonge Bruce J. Monash University NATIONALLICENCE 773 0- Behaviour Change Cambridge University Press 15/2(1998-06), 98-106 0813-4839 15:2<98 1998 15 BEC CC0 http://creativecommons.org/publicdomain/zero/1.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-cambridge